NCT06462417View on ClinicalTrials.gov

Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Allergic Rhinitis
Interventions
DRUG

Arbidol

Arbidol Hydrochloride Tablets 0.2g/d for 2 weeks

Trial Locations (2)

430000

RECRUITING

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan

430030

RECRUITING

Department of ENT, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

National Natural Science Foundation of China

OTHER_GOV

lead

Zheng Liu

OTHER